Filed Pursuant to Rule 424(b)(5)
Registration No. 333-265488
PROSPECTUS SUPPLEMENT NO. 2
(To Prospectus dated June 8, 2022 and
Prospectus Supplement dated January 17, 2024 and
Prospectus Supplement No. 1 dated February 23, 2024)
$1,000,000,000
Common Stock
This prospectus supplement no. 2 (this “prospectus supplement no. 2”) is being filed to update, amend and supplement certain information in the prospectus supplement, dated and filed with the Securities and Exchange Commission on January 17, 2024 (the “prospectus supplement”) and amendment no. 1 to the prospectus supplement dated and filed with the Securities and Exchange Commission on February 23, 2024 (the “prospectus supplement no. 1”), relating to the offer and sale of shares of our common stock having an aggregate gross sales price of up to $1,000,000,000, from time to time through or to B. Riley Securities, Inc. (“B. Riley Securities”), as sales agent or principal, pursuant to the At Market Issuance Sales Agreement, dated January 17, 2024 (the “Original Sales Agreement”), as amended by Amendment No. 1 to the At Market Issuance Sales Agreement, dated February 23, 2024 (together with the Original Sales Agreement, the “Sales Agreement”), with B. Riley Securities. This prospectus supplement no. 2 should be read in conjunction with the prospectus supplement and prospectus supplement no. 1.
As of the date of this prospectus supplement no. 2, we have offered and sold 219,835,221 shares of our common stock having an aggregate gross sales price of approximately $677,245,001 under the Sales Agreement and shares of our common stock having an aggregate gross sales price of $624,828,005 remain available for issuance and sale under the Sales Agreement.
On November 7, 2024, we entered into Amendment No. 2 to the At Market Issuance Sales Agreement (“Amendment No. 2” and together with the Sales Agreement, the “Amended Sales Agreement”) with B. Riley Securities. Amendment No. 2 increased the aggregate gross sales price of the Company’s common stock we may offer and sell pursuant to the Amended Sales Agreement by $375,171,995 to $1,000,000,000.
In addition, Amendment No. 2 provides that from and after the date hereof, through and including February 7, 2025, we will have the right, but not the obligation, from time to time at our sole discretion, to direct B. Riley Securities on any day to act on a principal basis and purchase from us $11,000,000 (the “Maximum Commitment Advance Purchase Amount”), and to purchase in principal transactions (including any shares sold by B. Riley Securities in agency transactions) in any calendar week up to $55,000,000 (the “Maximum Commitment Advance Purchase Amount Cap”), subject to certain conditions. If our market capitalization is less than $1,000,000,000 on and after February 8, 2025, the Maximum Commitment Advance Purchase Amount shall be decreased to $10,000,000 and the Maximum Commitment Advance Purchase Amount Cap shall be decreased to $30,000,000.
This prospectus supplement no. 2 should be read in conjunction with the prospectus supplement and prospectus supplement no. 1, and is qualified by reference thereto. Unless otherwise indicated, all other information included in the prospectus supplement, as amended by prospectus supplement no. 1, that is not inconsistent with the information set forth in this prospectus supplement no. 2 remains unchanged. This prospectus supplement no. 2 is not complete without, and may only be delivered or utilized in connection with, the prospectus supplement, prospectus supplement no. 1 and any other future amendments or supplements thereto.
Our common stock is listed on the Nasdaq Capital Market under the symbol “PLUG.” On November 6, 2024, the last reported sale price of our common stock on the Nasdaq Capital Market was $1.97 per share.
Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties referenced under the heading “Risk Factors” beginning on page S-6 of the prospectus supplement and in the other documents that are incorporated by reference in the prospectus supplement.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
B. Riley Securities
The date of this prospectus supplement no. 2 is November 7, 2024.